{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:32:06Z","timestamp":1790451126074,"version":"4.1.0"},"reference-count":31,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,3,30]]},"DOI":"10.1536\/ihj.18-288","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T22:43:44Z","timestamp":1549579424000},"page":"318-326","source":"Crossref","is-referenced-by-count":3,"title":["A Decision Tree-Based Survival Analysis of Patients with a History of Inappropriate Implantable Cardioverter-Defibrillator Therapy"],"prefix":"10.1536","volume":"60","author":[{"given":"Masaru","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Fujita Health University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Okajima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Himeji Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimane","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Himeji Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuro","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Asai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ichinomiya Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Takagi","sequence":"additional","affiliation":[{"name":"Division of Cardiac Arrhythmia, Cardiovascular Center, Department of Medicine II, Kansai Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunobu","family":"Kasai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ise Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kiyono","sequence":"additional","affiliation":[{"name":"Division of Bioengineering, Graduate School of Engineering Science, Osaka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moss AJ, Zareba W, Hall WJ, <i>et al<\/i>. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.","DOI":"10.1056\/NEJMoa013474"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Daubert JP, Zareba W, Cannom DS, <i>et al<\/i>. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-65.","DOI":"10.1016\/j.jacc.2007.09.073"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. van Rees JB, Borleffs CJ, de Bie MK, <i>et al<\/i>. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57: 556-62.","DOI":"10.1016\/j.jacc.2010.06.059"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Watanabe E, Okajima K, Shimane A, <i>et al<\/i>. Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing. J Interv Card Electrophysiol 2017; 49: 271-80.","DOI":"10.1007\/s10840-017-0272-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Taguchi Y, Ishikawa T, Matsumoto K, <i>et al<\/i>. An inappropriate shock case early after implantation of a subcutaneous cardiac defibrillator by subcutaneous entrapped air. Int Heart J 2018; 59: 417-9.","DOI":"10.1536\/ihj.17-117"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Schron EB, Exner DV, Yao Q, <i>et al<\/i>. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-94.","DOI":"10.1161\/hc0502.103330"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bourke JP, Turkington D, Thomas G, McComb JM, Tynan M. Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators. Heart 1997; 78: 581-3.","DOI":"10.1136\/hrt.78.6.581"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Vollmann D, Luthje L, Vonhof S, Unterberg C. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart Rhythm 2005; 2: 307-9.","DOI":"10.1016\/j.hrthm.2004.11.019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Poole JE, Johnson GW, Hellkamp AS, <i>et al<\/i>. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359: 1009-17.","DOI":"10.1056\/NEJMoa071098"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010; 7: 353-60.","DOI":"10.1016\/j.hrthm.2009.11.027"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Qian Z, Zhang Z, Guo J, <i>et al<\/i>. Association of implantable cardioverter defibrillator therapy with all-cause mortality-a systematic review and meta-analysis. Pacing Clin Electrophysiol 2016; 39: 81-8.","DOI":"10.1111\/pace.12766"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Moss AJ, Schuger C, Beck CA, <i>et al<\/i>. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367: 2275-83.","DOI":"10.1056\/NEJMoa1211107"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ruwald AC, Schuger C, Moss AJ, <i>et al<\/i>. Mortality reduction in relation to implantable cardioverter defibrillator programming in the multicenter automatic defibrillator implantation trial-reduce inappropriate therapy (MADIT-RIT). Circ Arrhythm Electrophysiol 2014; 7: 785-92.","DOI":"10.1161\/CIRCEP.114.001623"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2014; 7: 164-70.","DOI":"10.1161\/CIRCEP.113.001217"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kurita T, Noda T, Nitta T, <i>et al<\/i>. Nippon storm study design. J Arrhythm 2012; 28: 277-9.","DOI":"10.1016\/j.joa.2012.04.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Watanabe E, Kasai A, Fujii E, Yamashiro K, Brugada P. Reliability of implantable cardioverter defibrillator home monitoring in forecasting the need for regular office visits, and patient perspective. Circ J 2013; 77: 2704-11.","DOI":"10.1253\/circj.CJ-13-0387"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Klein RC, Raitt MH, Wilkoff BL, <i>et al<\/i>. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 2003; 14: 940-8.","DOI":"10.1046\/j.1540-8167.2003.01554.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wasfy MM, Baggish AL. Exercise dose in clinical practice. Circulation 2016; 133: 2297-313.","DOI":"10.1161\/CIRCULATIONAHA.116.018093"},{"key":"19","unstructured":"19. Breiman L, Friedman JH, Olshen RA, Stone CJ. <i>Classification and regression trees<\/i>. Boca Raton, FL: Chapman and Hall\/CRC; 1984."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Daimee UA, Vermilye K, Rosero S, <i>et al<\/i>. Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT-RIT substudy. Pacing Clin Electrophysiol 2017; 40: 1405-11.","DOI":"10.1111\/pace.13216"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Thijssen J, Borleffs CJ, van Rees JB, <i>et al<\/i>. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. Eur Heart J 2011; 32: 2678-87.","DOI":"10.1093\/eurheartj\/ehr161"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bilchick KC, Stukenborg GJ, Kamath S, Cheng A. Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol 2012; 60: 1647-55.","DOI":"10.1016\/j.jacc.2012.07.028"},{"key":"23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.hrthm.2010.07.015","volume":"7","year":"2010","unstructured":"23. Hammill SC, Kremers MS, Stevenson LW, <i>et al<\/i>. Review of the registry&apos;s fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010; 7: 1340-5.","journal-title":"Heart Rhythm","ISSN":"https:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Alba AC, Braga J, Gewarges M, Walter SD, Guyatt GH, Ross HJ. Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis. Can J Cardiol 2013; 29: 1729-40.","DOI":"10.1016\/j.cjca.2013.09.024"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ooka J, Tanaka H, Hatani Y, <i>et al<\/i>. Risk stratification of future left ventricular dysfunction for patients with indications for right ventricular pacing due to bradycardia. Int Heart J 2017; 58: 724-30.","DOI":"10.1536\/ihj.16-415"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fu L, Zhou Q, Zhu W, <i>et al<\/i>. Do implantable cardioverter defibrillators reduce mortality in patients with chronic kidney disease at all stages? Int Heart J 2017; 58: 371-7.","DOI":"10.1536\/ihj.16-357"},{"key":"27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.hrthm.2011.08.031","volume":"9","year":"2012","unstructured":"27. Kramer DB, Friedman PA, Kallinen LM, <i>et al<\/i>. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm 2012; 9: 42-6.","journal-title":"Heart Rhythm","ISSN":"https:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Parkash R, Stevenson WG, Epstein LM, Maisel WH. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J 2006; 151: 397-403.","DOI":"10.1016\/j.ahj.2005.04.009"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ishizue N, Niwano S, Fukaya H, <i>et al<\/i>. The J-wave as a predictor of life-threatening arrhythmia in ICD patients. Int Heart J 2017; 58: 36-42.","DOI":"10.1536\/ihj.16-071"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ponikowski P, Voors AA, Anker SD, <i>et al<\/i>. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hindricks G, Varma N, Kacet S, <i>et al<\/i>. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J 2017; 38: 1749-55.","DOI":"10.1093\/eurheartj\/ehx015"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/2\/60_18-288\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T03:37:57Z","timestamp":1553398677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/2\/60_18-288\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.18-288","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,30]]}}}